Cargando…
Recycling Discarded Drugs: Improving Access to Oral Antineoplastic Drugs
It is common for patients to have limited access to oral antineoplastics or to discontinue treatment because of cost. Such oral treatments are also discontinued because of toxicity, disease progression, or death, resulting in unused portions of these medications. Policies for the subsequent use or d...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6519754/ https://www.ncbi.nlm.nih.gov/pubmed/30568023 http://dx.doi.org/10.1634/theoncologist.2018-0565 |
_version_ | 1783418658903556096 |
---|---|
author | Layton, Jodi L. Lewis, Brian Ryan, Charles Beer, Tomasz M. Sartor, Oliver |
author_facet | Layton, Jodi L. Lewis, Brian Ryan, Charles Beer, Tomasz M. Sartor, Oliver |
author_sort | Layton, Jodi L. |
collection | PubMed |
description | It is common for patients to have limited access to oral antineoplastics or to discontinue treatment because of cost. Such oral treatments are also discontinued because of toxicity, disease progression, or death, resulting in unused portions of these medications. Policies for the subsequent use or destruction of unused drugs exist, but none completely address the need for methods of recycling back to the patients in need. This article addresses this wastefulness and ways to minimize it so that more patients benefit. |
format | Online Article Text |
id | pubmed-6519754 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | John Wiley & Sons, Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-65197542019-06-20 Recycling Discarded Drugs: Improving Access to Oral Antineoplastic Drugs Layton, Jodi L. Lewis, Brian Ryan, Charles Beer, Tomasz M. Sartor, Oliver Oncologist Commentaries It is common for patients to have limited access to oral antineoplastics or to discontinue treatment because of cost. Such oral treatments are also discontinued because of toxicity, disease progression, or death, resulting in unused portions of these medications. Policies for the subsequent use or destruction of unused drugs exist, but none completely address the need for methods of recycling back to the patients in need. This article addresses this wastefulness and ways to minimize it so that more patients benefit. John Wiley & Sons, Inc. 2018-12-19 2019-03 /pmc/articles/PMC6519754/ /pubmed/30568023 http://dx.doi.org/10.1634/theoncologist.2018-0565 Text en © AlphaMed Press 2018 |
spellingShingle | Commentaries Layton, Jodi L. Lewis, Brian Ryan, Charles Beer, Tomasz M. Sartor, Oliver Recycling Discarded Drugs: Improving Access to Oral Antineoplastic Drugs |
title | Recycling Discarded Drugs: Improving Access to Oral Antineoplastic Drugs |
title_full | Recycling Discarded Drugs: Improving Access to Oral Antineoplastic Drugs |
title_fullStr | Recycling Discarded Drugs: Improving Access to Oral Antineoplastic Drugs |
title_full_unstemmed | Recycling Discarded Drugs: Improving Access to Oral Antineoplastic Drugs |
title_short | Recycling Discarded Drugs: Improving Access to Oral Antineoplastic Drugs |
title_sort | recycling discarded drugs: improving access to oral antineoplastic drugs |
topic | Commentaries |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6519754/ https://www.ncbi.nlm.nih.gov/pubmed/30568023 http://dx.doi.org/10.1634/theoncologist.2018-0565 |
work_keys_str_mv | AT laytonjodil recyclingdiscardeddrugsimprovingaccesstooralantineoplasticdrugs AT lewisbrian recyclingdiscardeddrugsimprovingaccesstooralantineoplasticdrugs AT ryancharles recyclingdiscardeddrugsimprovingaccesstooralantineoplasticdrugs AT beertomaszm recyclingdiscardeddrugsimprovingaccesstooralantineoplasticdrugs AT sartoroliver recyclingdiscardeddrugsimprovingaccesstooralantineoplasticdrugs |